137 related articles for article (PubMed ID: 23815500)
1. Oxidized fatty acids: A potential pathogenic link between fatty liver and type 2 diabetes in obese adolescents?
Santoro N; Caprio S; Giannini C; Kim G; Kursawe R; Pierpont B; Shaw MM; Feldstein AE
Antioxid Redox Signal; 2014 Jan; 20(2):383-9. PubMed ID: 23815500
[TBL] [Abstract][Full Text] [Related]
2. Role of Patatin-Like Phospholipase Domain-Containing 3 Gene for Hepatic Lipid Content and Insulin Resistance in Diabetes.
Zaharia OP; Strassburger K; Knebel B; Kupriyanova Y; Karusheva Y; Wolkersdorfer M; Bódis K; Markgraf DF; Burkart V; Hwang JH; Kotzka J; Al-Hasani H; Szendroedi J; Roden M;
Diabetes Care; 2020 Sep; 43(9):2161-2168. PubMed ID: 32910776
[TBL] [Abstract][Full Text] [Related]
3. A common variant in the PNPLA3 gene is a risk factor for non-alcoholic fatty liver disease in obese Taiwanese children.
Lin YC; Chang PF; Hu FC; Yang WS; Chang MH; Ni YH
J Pediatr; 2011 May; 158(5):740-4. PubMed ID: 21168155
[TBL] [Abstract][Full Text] [Related]
4. The association between hepatic fat content and liver injury in obese children and adolescents: effects of ethnicity, insulin resistance, and common gene variants.
Santoro N; Feldstein AE; Enoksson E; Pierpont B; Kursawe R; Kim G; Caprio S
Diabetes Care; 2013 May; 36(5):1353-60. PubMed ID: 23275357
[TBL] [Abstract][Full Text] [Related]
5. A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents.
Santoro N; Kursawe R; D'Adamo E; Dykas DJ; Zhang CK; Bale AE; Calí AM; Narayan D; Shaw MM; Pierpont B; Savoye M; Lartaud D; Eldrich S; Cushman SW; Zhao H; Shulman GI; Caprio S
Hepatology; 2010 Oct; 52(4):1281-90. PubMed ID: 20803499
[TBL] [Abstract][Full Text] [Related]
6. A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population.
Verrijken A; Beckers S; Francque S; Hilden H; Caron S; Zegers D; Ruppert M; Hubens G; Van Marck E; Michielsen P; Staels B; Taskinen MR; Van Hul W; Van Gaal L
Obesity (Silver Spring); 2013 Oct; 21(10):2138-45. PubMed ID: 23512881
[TBL] [Abstract][Full Text] [Related]
7. Adipose tissue is inflamed in NAFLD due to obesity but not in NAFLD due to genetic variation in PNPLA3.
Lallukka S; Sevastianova K; Perttilä J; Hakkarainen A; Orho-Melander M; Lundbom N; Olkkonen VM; Yki-Järvinen H
Diabetologia; 2013 Apr; 56(4):886-92. PubMed ID: 23334462
[TBL] [Abstract][Full Text] [Related]
8. Hepatic fat accumulation is modulated by the interaction between the rs738409 variant in the PNPLA3 gene and the dietary omega6/omega3 PUFA intake.
Santoro N; Savoye M; Kim G; Marotto K; Shaw MM; Pierpont B; Caprio S
PLoS One; 2012; 7(5):e37827. PubMed ID: 22629460
[TBL] [Abstract][Full Text] [Related]
9. Genetic determinants of hepatic steatosis and serum cytokeratin-18 fragment levels in Taiwanese children.
Lin YC; Chang PF; Chang MH; Ni YH
Liver Int; 2018 Jul; 38(7):1300-1307. PubMed ID: 29314568
[TBL] [Abstract][Full Text] [Related]
10. PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery.
Krawczyk M; Jiménez-Agüero R; Alustiza JM; Emparanza JI; Perugorria MJ; Bujanda L; Lammert F; Banales JM
Surg Obes Relat Dis; 2016 Dec; 12(10):1838-1846. PubMed ID: 27576208
[TBL] [Abstract][Full Text] [Related]
11. Specifically PNPLA3-mediated accumulation of liver fat in obese patients with type 2 diabetes.
Petit JM; Guiu B; Masson D; Duvillard L; Jooste V; Buffier P; Terriat B; Bouillet B; Brindisi MC; Loffroy R; Robin I; Hillon P; Cercueil JP; Verges B
J Clin Endocrinol Metab; 2010 Dec; 95(12):E430-6. PubMed ID: 20826584
[TBL] [Abstract][Full Text] [Related]
12. Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity.
Guichelaar MM; Gawrieh S; Olivier M; Viker K; Krishnan A; Sanderson S; Malinchoc M; Watt KD; Swain JM; Sarr M; Charlton MR
Obesity (Silver Spring); 2013 Sep; 21(9):1935-41. PubMed ID: 23418085
[TBL] [Abstract][Full Text] [Related]
13. The PNPLA3 rs738409 C>G variant interacts with changes in body weight over time to aggravate liver steatosis, but reduces the risk of incident type 2 diabetes.
Xia MF; Lin HD; Chen LY; Wu L; Ma H; Li Q; Aleteng Q; Hu Y; He WY; Gao J; Bian H; Li XY; Gao X
Diabetologia; 2019 Apr; 62(4):644-654. PubMed ID: 30673802
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Hepassocin in Diabetic Patients with Nonalcoholic Fatty Liver Disease May Facilitate Increased Hepatic Lipid Accumulation.
Abdelmoemen G; Khodeir SA; Zaki AN; Kassab M; Abou-Saif S; Abd-Elsalam S
Endocr Metab Immune Disord Drug Targets; 2019; 19(2):185-188. PubMed ID: 30009716
[TBL] [Abstract][Full Text] [Related]
15. Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis.
Kim JY; Park KJ; Hwang JY; Kim GH; Lee D; Lee YJ; Song EH; Yoo MG; Kim BJ; Suh YH; Roh GS; Gao B; Kim W; Kim WH
J Hepatol; 2017 Aug; 67(2):349-359. PubMed ID: 28365312
[TBL] [Abstract][Full Text] [Related]
16. Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study.
Eriksson JW; Lundkvist P; Jansson PA; Johansson L; Kvarnström M; Moris L; Miliotis T; Forsberg GB; Risérus U; Lind L; Oscarsson J
Diabetologia; 2018 Sep; 61(9):1923-1934. PubMed ID: 29971527
[TBL] [Abstract][Full Text] [Related]
17. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
18. Circulating triacylglycerol signatures in nonalcoholic fatty liver disease associated with the I148M variant in PNPLA3 and with obesity.
Hyysalo J; Gopalacharyulu P; Bian H; Hyötyläinen T; Leivonen M; Jaser N; Juuti A; Honka MJ; Nuutila P; Olkkonen VM; Oresic M; Yki-Järvinen H
Diabetes; 2014 Jan; 63(1):312-22. PubMed ID: 24009255
[TBL] [Abstract][Full Text] [Related]
19. PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.
Aragonès G; Auguet T; Armengol S; Berlanga A; Guiu-Jurado E; Aguilar C; Martínez S; Sabench F; Porras JA; Ruiz MD; Hernández M; Sirvent JJ; Del Castillo D; Richart C
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27128907
[TBL] [Abstract][Full Text] [Related]
20. Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 Diabetes.
Levelt E; Pavlides M; Banerjee R; Mahmod M; Kelly C; Sellwood J; Ariga R; Thomas S; Francis J; Rodgers C; Clarke W; Sabharwal N; Antoniades C; Schneider J; Robson M; Clarke K; Karamitsos T; Rider O; Neubauer S
J Am Coll Cardiol; 2016 Jul; 68(1):53-63. PubMed ID: 27364051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
